Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500102686Phase 4Not yet recruiting
Phase 4, randomised trial of sodium fluoride in carious lesion (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: DMF index (decayed, missing, and filled teeth) at 12 months. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500102686.